Mello de Paula A J
Pharmacology. 1983;27 Suppl 2:188-95. doi: 10.1159/000137926.
The safety and efficacy of zopiclone (7.5 mg) and pentobarbitone (100 mg) were compared in 60 adult outpatients suffering from insomnia. The patients were randomly assigned to one of the two treatment groups, and the medication was taken at bedtime for 16 days. Zopiclone and pentobarbitone, compared with placebo, improved sleep onset, duration of sleep, number of night time awakenings, and quality of sleep. Zopiclone was superior to pentobarbitone with regard to sleep quality, judgement of therapy, and condition in the morning. Side effects were reported in each treatment group, but were less frequent in the zopiclone group (p less than 0.005). Zopiclone is a useful drug for the treatment of sleep disturbances, not only because of its efficacy, but also because of its tolerability.
对60名成年失眠门诊患者比较了佐匹克隆(7.5毫克)和戊巴比妥(100毫克)的安全性和有效性。患者被随机分配到两个治疗组之一,药物在睡前服用16天。与安慰剂相比,佐匹克隆和戊巴比妥改善了入睡情况、睡眠时间、夜间觉醒次数和睡眠质量。在睡眠质量、治疗评价和早晨状况方面,佐匹克隆优于戊巴比妥。每个治疗组均报告有副作用,但佐匹克隆组的副作用较少(p<0.005)。佐匹克隆是一种治疗睡眠障碍的有效药物,不仅因其疗效,还因其耐受性。